A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Levonordefrin | CAS 829-74-3 - Request Quote

Picture of Levonordefrin

Levonordefrin

SZ CAT No:SZ-L135001
CAS No
829-74-3
Mol.F.
C9H13NO3
Mol.Wt.
183.2
Inv. Status
Synthesis on demand

Chemical Name :

Synonym :

Shipping Temperature :

HSN Code :

Country of Origin :

Smiles :

Usage Note:

Levonordefrin is chemically (-)-α-(1-aminoethyl)-3,4-dihydroxybenzyl alcohol) (as per USP). It is also known as Neo-Cobefrine ; α-Methylnorepinephrine. Levonordefrin is supplied with detailed characterization data compliant with regulatory guideline. Levonordefrin can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Levonordefrin.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

Applications & Regulatory Use Cases

Buy 829-74-3

Purchase 829-74-3

Order 829-74-3

Enquire 829-74-3

price of 829-74-3

829-74-3 Supplier

829-74-3 Manufacturer

829-74-3 Exporter

buy high quality Levonordefrin

Purchase Levonordefrin

Levonordefrin suppliers

Levonordefrin manufacturers

Levonordefrin price

Order Levonordefrin

Enquire Levonordefrin

Levonordefrin cost

Levonordefrin Supplier

Levonordefrin Distributor

Levonordefrin for Method Validation

Levonordefrin Reference Standard

Levonordefrin for ANDA Filing

Levonordefrin for Forced Degradation Studies

Levonordefrin Identification Standards

Levonordefrin for DMF Filing

ℹ️

Disclaimer

SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.

SynZeal will update these details as per new developments or findings in product specifications without further notice.